Susan Hasty, Publisher
Table of Contents . . . March 7th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Hepatocellular Carcinoma - Electroporation-assisted gene therapy kills cells in primary liver cancer
Pancreatic Cancer - Inhibitor TIMP-1 a potential gene therapy target for cancer of pancreas
Cancer Therapy - Retinoic acid might be of more harm than benefit to cancer patients
Chemotherapy - Viral vector aids therapies that cause cellular suicide
Hemophilia A - Engineered cells expand, produce therapeutic levels of coagulation factor
AIDS Vaccines - Epimmune provides HIV vaccine program update
Allergy Medicine - Potential vaccine boosts hope for pollen relief
Cancer Gene Therapy - Onyx awarded European patent for adenovirus-based treatment
Diagnostic Imaging - Contrast agent improves some aspects of visualizing tumor vascularity
Facilities - New Vical corporate center to reflect expanded focus
Gene Delivery - Company gains access to vectors of gene therapies that inhibit angiogenesis
Hemophilia B - Avigen proceeds with liver infusion of Coagulin-B therapy
Leukemia - Tumor suppressor genes can block leukemic cell proliferation
Organ Grafting - Modified T cells could deliver transgenes to tissues following transplantation
Patents - Which came first, the cow or the sheep?
Patient Safety - NCQA convenes human research protection advisory council
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.